Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03043807
What this trial is testing

Definitive Therapy to Treat Prostate Cancer After Prostatectomy

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26
Testing effectiveness (Phase 2)Study completedNCT00967707
What this trial is testing

Population Pharmacokinetic-pharmacodynamic (PK-PD) Modeling of Co-administered Gabapentin in Neuropathic Pain

Who this might be right for
Post-traumatic Neuropathic Pain
Uppsala University 30
Testing effectiveness (Phase 2)UnknownNCT02488707
What this trial is testing

Minimally Invasive Sphincter Sparing Total Mesorectal Excision for Ultra-low Rectal Cancer After Initial Chemo-radiotherapy (MISS-TRICR).

Who this might be right for
Rectal Cancer
Mansoura University 250
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381543
What this trial is testing

Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone

Who this might be right for
Localized Small Cell Lung Cancer
Peking University Cancer Hospital & Institute 76
Not applicableStudy completedNCT05118178
What this trial is testing

Atherosclerosis in Chemotherapy-related Cardiotoxicity

Who this might be right for
CardiotoxicityAtherosclerosis
Maria Sklodowska-Curie National Research Institute of Oncology 80
Post-approval studies (Phase 4)WithdrawnNCT02760615
What this trial is testing

Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study

Who this might be right for
Colitis, UlcerativeCrohn Disease
Takeda
Not applicableStudy completedNCT04500535
What this trial is testing

Participants With Advanced Non-Small Cell Lung Cancer Treated With Nivolumab in France After at Least One Prior Chemotherapy-based Treatment by Lung Initiative on Sequence Therapy

Who this might be right for
Lung Cancer
Bristol-Myers Squibb 535
Testing effectiveness (Phase 2)Study completedNCT01297543
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+1 more
Cellerant Therapeutics 45
Testing effectiveness (Phase 2)Study completedNCT03023878
What this trial is testing

Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma

Who this might be right for
High-risk Diffuse Large B-Cell Lymphoma
Amgen 47
Testing effectiveness (Phase 2)UnknownNCT02588781
What this trial is testing

Pemetrexed Alone as Salvage Treatment in Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study

Who this might be right for
Colorectal Cancer
Samsung Medical Center 23
Testing effectiveness (Phase 2)Ended earlyNCT04549428
What this trial is testing

Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced Oligoprogressive NSCLC

Who this might be right for
NSCLC Stage IV
Oncology Institute of Southern Switzerland 12
Testing effectiveness (Phase 2)Ended earlyNCT00541112
What this trial is testing

Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery

Who this might be right for
Colorectal Cancer
UNICANCER 19
Not applicableUnknownNCT03575650
What this trial is testing

Early Detection of Imaging-derived Subclinical Cardiac Injuries

Who this might be right for
Cardiovascular Diseases
University Medical Center Groningen 148
Large-scale testing (Phase 3)Study completedNCT02312258
What this trial is testing

Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT)

Who this might be right for
Multiple Myeloma
Takeda 706
Testing effectiveness (Phase 2)Ended earlyNCT04541017
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment

Who this might be right for
Mycosis FungoidesRecurrent Mycosis FungoidesRecurrent Mycosis Fungoides and Sezary Syndrome+9 more
National Cancer Institute (NCI) 8
Not applicableLooking for participantsNCT06885476
What this trial is testing

Infusion of Alloreactive nk Cells for Mrd-positive Aml Patients

Who this might be right for
Acute Myeloid LeukemiaMinimal Residual DiseaseNatural Killer Cell
IRCCS Azienda Ospedaliero-Universitaria di Bologna 22
Not applicableUnknownNCT01684189
What this trial is testing

Registry of Febrile Neutropenia and Invasive Fungal Infections

Who this might be right for
Hematological DiseaseFebrile NeutropeniaFungal Infections
Chang Gung Memorial Hospital 100
Large-scale testing (Phase 3)Looking for participantsNCT05772208
What this trial is testing

Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 459
Testing effectiveness (Phase 2)UnknownNCT01369368
What this trial is testing

Treatment of Acute Leukemia Relapse After Allotransplantation

Who this might be right for
Acute Myeloid Leukemia
University of Bergen 20
Not applicableStudy completedNCT04368468
What this trial is testing

Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BC

Who this might be right for
Triple Negative Breast Cancer
Institut Claudius Regaud 100
Next Page